Top search results

At the Conference on Retroviruses and Opportunistic Infections (CROI 2026), Professor Jürgen Rockstroh from the University of Bonn spoke to aidsmap.com's Roger Pebody about two-drug HIV treatment doravirine and islatravir.

At CROI 2024, Dr Amy Colson from the Community Resource Initiative in Boston spoke to aidsmap's Roger Pebody about islatravir and lenacapavir as a once-weekly oral HIV treatment.

 At CROI 2023, Professor Joseph Eron from University of North Carolina spoke to NAM's Roger Pebody about lenacapavir and two broadly neutralising antibodies for treatment.

Dr Roger Shapiro from Harvard University talks about antibody treatment for children with HIV and could it be used instead of pills at CROI 2022.

Professor Jean-Michel Molina of Hôpital Saint-Louis in Paris talks about injectable lenacapavir, a capsid inhibitor currently under development, for people with multidrug-resistant HIV at IAS 2021.

At IAS 2021, Professor Samir Gupta of Indiana University talks about lenacapavir, an experimental capsid inhibitor, for people starting HIV treatment.

Our HIV Community Forum shared information on HIV treatment and prevention from the 9th IAS Conference on HIV Science. With Dr Tristan Barber, from Chelsea and Westminster NHS Foundation Trust; Memory Sachikonye, from UK Community Advisory Board (UK-CAB); and Gus Cairns and Roger Pebody, from NAM aidsmap.